Predictive factors for switching in patients with psoriatic arthritis undergoing anti-TNFα, anti-IL12/23, or anti-IL17 drugs: a 15-year monocentric real-life study
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.